173 related articles for article (PubMed ID: 8643591)
1. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.
Hofer MF; Newell K; Duke RC; Schlievert PM; Freed JH; Leung DY
Proc Natl Acad Sci U S A; 1996 May; 93(11):5425-30. PubMed ID: 8643591
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
Hofer MF; Lester MR; Schlievert PM; Leung DY
Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303
[TBL] [Abstract][Full Text] [Related]
3. Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1.
Yokomizo Y; Mori Y; Shimoji Y; Shimizu S; Sentsui H; Kodama M; Igarashi H
J Vet Med Sci; 1995 Apr; 57(2):299-305. PubMed ID: 7492650
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effects of staphylococcal superantigen TSST-1 on IgE synthesis in atopic dermatitis.
Lester MR; Hofer MF; Renz H; Trumble AE; Gelfand EW; Leung DY
Clin Immunol Immunopathol; 1995 Dec; 77(3):332-8. PubMed ID: 7586744
[TBL] [Abstract][Full Text] [Related]
5. Inverse relationship between toxic shock syndrome toxin-1 antibodies and interferon-γ and interleukin-6 in peripheral blood mononuclear cells from patients with pediatric tonsillitis caused by Staphylococcus aureus.
Chen Y; Huang Y; Liang B; Dong H; Yao S; Xie Y; Long Y; Zhong H; Yang Y; Zhu B; Gong S; Zhou Z
Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():211-217. PubMed ID: 28483238
[TBL] [Abstract][Full Text] [Related]
6. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
Hashimoto K; Shigeta S; Baba M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
[TBL] [Abstract][Full Text] [Related]
7. The superantigen toxic shock syndrome toxin-1 induces CD40 ligand expression and modulates IgE isotype switching.
Jabara HH; Geha RS
Int Immunol; 1996 Oct; 8(10):1503-10. PubMed ID: 8921429
[TBL] [Abstract][Full Text] [Related]
8. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
[TBL] [Abstract][Full Text] [Related]
9. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
Mourad W; Scholl P; Diaz A; Geha R; Chatila T
J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
[TBL] [Abstract][Full Text] [Related]
10. Cytokine secretion induced by superantigens in peripheral blood mononuclear cells, lamina propria lymphocytes, and intraepithelial lymphocytes.
Sperber K; Silverstein L; Brusco C; Yoon C; Mullin GE; Mayer L
Clin Diagn Lab Immunol; 1995 Jul; 2(4):473-7. PubMed ID: 7583927
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria.
Calandra T; Spiegel LA; Metz CN; Bucala R
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11383-8. PubMed ID: 9736745
[TBL] [Abstract][Full Text] [Related]
12. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
[TBL] [Abstract][Full Text] [Related]
13. Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytes.
Wood SC; Holsapple MP
Fundam Appl Toxicol; 1993 Apr; 20(3):280-7. PubMed ID: 8504901
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen.
Hofer MF; Harbeck RJ; Schlievert PM; Leung DY
J Invest Dermatol; 1999 Feb; 112(2):171-6. PubMed ID: 9989792
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1.
Micusan VV; Desrosiers M; Gosselin J; Mercier G; Oth D; Bhatti AR; Heremans H; Billiau A
Rev Infect Dis; 1989; 11 Suppl 1():S305-12. PubMed ID: 2494690
[TBL] [Abstract][Full Text] [Related]
16. Activation of human vascular endothelial cells by IFN-gamma: acquisition of HLA class II expression, TSST-1-binding activity and accessory activity in T cell activation by the toxin.
Araake M; Uchiyama T; Imanishi K; Yan XJ
Int Arch Allergy Appl Immunol; 1991; 96(1):55-61. PubMed ID: 1752697
[TBL] [Abstract][Full Text] [Related]
17. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with chronic renal failure on hemodialysis treatment.
Konno O; Hirano T; Katsuyama K; Oka K; Matsuno N; Nagao T
Transpl Immunol; 2007 Apr; 17(3):187-92. PubMed ID: 17331845
[TBL] [Abstract][Full Text] [Related]
18. Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes.
See RH; Kum WW; Chang AH; Goh SH; Chow AW
Infect Immun; 1992 Jul; 60(7):2612-8. PubMed ID: 1612731
[TBL] [Abstract][Full Text] [Related]
19. MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice.
Radons J; Burkart V; Kolb H
Diabetes; 1997 Mar; 46(3):379-85. PubMed ID: 9032092
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcal toxic shock syndrome toxin-1 inhibits monocyte apoptosis.
Bratton DL; May KR; Kailey JM; Doherty DE; Leung DY
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):895-900. PubMed ID: 10329825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]